Saturday 17 October 2026
Export TLX’s income statement to Excel — free account
Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited’s revenue for fiscal 2025 (year ended December 2025) was $803.8 million, up 55.6% from fiscal 2024. Insiders bought in the last twelve months.
10.69
0.12
+1.14%
Follow TLX
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Cash and Short Term Investments |
81.88 | 440.00 | 141.87 |
Receivables |
43.04 | 86.93 | 129.20 |
Inventory |
11.50 | 23.62 | 37.08 |
Other current assets |
18.06 | 19.57 | 22.13 |
Total current assets |
154.48 | 570.12 | 330.28 |
Property, Plant, Equpment (Net) |
15.39 | 27.84 | 58.66 |
Long-term receivables |
0.39 | — | — |
Goodwill and Intangible Assets (Total) |
72.86 | 257.86 | 592.82 |
Long Term Assets (Tax, Deferred) |
13.59 | 28.92 | 59.35 |
Long-term assets (Other) |
8.15 | 49.84 | 65.92 |
Total non-current assets |
115.24 | 370.26 | 833.71 |
Total Assets |
269.72 | 940.38 | 1,163.99 |
Accounts Payable |
54.28 | 86.79 | 150.35 |
Current Part of Debt |
0.64 | 11.76 | 13.11 |
Current Part of Capital Lease |
0.40 | 1.55 | 5.55 |
Current Part of Taxes to Pay |
12.73 | 30.09 | 30.74 |
Other current liabilities |
41.62 | 74.90 | 31.88 |
Total current liabilities |
109.67 | 205.09 | 231.62 |
Long Term Debt (Total) |
10.55 | 346.85 | 448.45 |
Pension and Post-Retirement Liabilities |
0.22 | 0.31 | 0.44 |
Long Term Tax Liability (Deferred) |
— | 5.80 | 44.71 |
Non-current Liabilities (Other) |
50.34 | 29.40 | 23.39 |
Total non-current liabilities |
61.11 | 382.35 | 516.99 |
Total liabilities |
170.78 | 587.44 | 748.61 |
Additional Paid In Capital |
(41.74) | 15.95 | (11.61) |
Common Stock (Net) |
296.50 | 414.01 | 479.96 |
Retained Earnings |
(175.18) | (152.91) | (154.54) |
Shareholders Equity (Other) |
19.36 | 75.89 | 101.56 |
Common Equity (Total) |
98.94 | 352.94 | 415.38 |
Shareholders Equity (Total) |
98.94 | 352.94 | 415.38 |
Shareholders Equity and Liabilities (Total) |
269.72 | 940.38 | 1,163.99 |
Shares (Common) |
323.73 | 334.73 | 338.78 |
Shareholders Equity (Tangible) |
26.08 | 95.08 | (177.45) |
Net Debt |
(70.68) | (81.38) | 319.69 |
Total Debt |
11.20 | 358.62 | 461.56 |
In millions of $ except per-share values · columns are period end dates